CH623062A5 - - Google Patents
Download PDFInfo
- Publication number
- CH623062A5 CH623062A5 CH1444875A CH1444875A CH623062A5 CH 623062 A5 CH623062 A5 CH 623062A5 CH 1444875 A CH1444875 A CH 1444875A CH 1444875 A CH1444875 A CH 1444875A CH 623062 A5 CH623062 A5 CH 623062A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- methylene
- hydrogen atom
- hydroxy
- pregnen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2453823A DE2453823C2 (de) | 1974-11-11 | 1974-11-11 | 11β,17α-Dihydroxy-15α,16α-methylen-1,4-pregnadien-3,20-dion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH623062A5 true CH623062A5 (cs) | 1981-05-15 |
Family
ID=5930733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1444875A CH623062A5 (cs) | 1974-11-11 | 1975-11-07 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4012510A (cs) |
| JP (2) | JPS645880B2 (cs) |
| BE (1) | BE835427A (cs) |
| CH (1) | CH623062A5 (cs) |
| DE (1) | DE2453823C2 (cs) |
| DK (1) | DK142057C (cs) |
| FR (1) | FR2290214A1 (cs) |
| GB (1) | GB1530615A (cs) |
| NL (1) | NL7513156A (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040265948A1 (en) * | 2003-06-27 | 2004-12-30 | White Michael Jon | Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters |
| DE102008026793A1 (de) * | 2008-06-02 | 2009-12-03 | Bayer Schering Pharma Aktiengesellschaft | C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate |
| US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
| BR112020016269A2 (pt) * | 2018-02-11 | 2020-12-15 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Reguladores derivados de esteroides, método para prepará- los e suas utilizações |
| EP4251634A1 (en) * | 2020-11-25 | 2023-10-04 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH573447A5 (en) * | 1971-06-11 | 1976-03-15 | Hoffmann La Roche | 21-hydroxy-11-beta-hydroxy (or 11-oxo) -15-beta, 16-beta - - methylene pregn-4-en-3,20-diones prepn - by 21-hydroxylation or oxi |
| US3438975A (en) * | 1966-07-01 | 1969-04-15 | Syntex Corp | 15alpha,16alpha-methylene pregnanes and 19-nor-pregnanes |
| CH531487A (de) * | 1969-12-17 | 1972-12-15 | Hoffmann La Roche | Verfahren zur Herstellung neuer Steroide der Pregnanreihe |
| US3700702A (en) * | 1970-12-02 | 1972-10-24 | Hoffmann La Roche | New 15{62 ,16{62 -methylene steroids |
| DE2246462C3 (de) * | 1972-09-21 | 1981-07-23 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | 15 α , 16 α -Methylen-4-pregnene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE2337333A1 (de) * | 1973-07-23 | 1975-02-20 | American Cyanamid Co | Steroidacetonide und ihre verwendung |
-
1974
- 1974-11-11 DE DE2453823A patent/DE2453823C2/de not_active Expired
-
1975
- 1975-11-07 CH CH1444875A patent/CH623062A5/de not_active IP Right Cessation
- 1975-11-10 GB GB46358/75A patent/GB1530615A/en not_active Expired
- 1975-11-10 BE BE161738A patent/BE835427A/xx not_active IP Right Cessation
- 1975-11-10 US US05/630,627 patent/US4012510A/en not_active Expired - Lifetime
- 1975-11-10 FR FR7534271A patent/FR2290214A1/fr active Granted
- 1975-11-10 DK DK503775A patent/DK142057C/da not_active IP Right Cessation
- 1975-11-10 NL NL7513156A patent/NL7513156A/xx not_active Application Discontinuation
- 1975-11-11 JP JP50135577A patent/JPS645880B2/ja not_active Expired
-
1986
- 1986-08-04 JP JP61182047A patent/JPS62187486A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NL7513156A (nl) | 1976-05-13 |
| JPS645880B2 (cs) | 1989-02-01 |
| DE2453823C2 (de) | 1984-08-09 |
| DK142057B (da) | 1980-08-18 |
| FR2290214B1 (cs) | 1978-08-18 |
| DE2453823A1 (de) | 1976-05-20 |
| FR2290214A1 (fr) | 1976-06-04 |
| GB1530615A (en) | 1978-11-01 |
| JPS5191392A (cs) | 1976-08-10 |
| DK503775A (da) | 1976-05-12 |
| US4012510A (en) | 1977-03-15 |
| JPH0148760B2 (cs) | 1989-10-20 |
| DK142057C (da) | 1981-01-19 |
| JPS62187486A (ja) | 1987-08-15 |
| BE835427A (fr) | 1976-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0072547A1 (de) | Neue 6-alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung | |
| DE1154102B (de) | Verfahren zur Herstellung therapeutisch wirksamer Steroidverbindungen | |
| DE2349022A1 (de) | Neue d-homo-steroide | |
| CH618704A5 (cs) | ||
| CH623062A5 (cs) | ||
| EP0054786B1 (de) | Neue 6-alpha-Methylhydrocortison-Derivate, ihre Herstellung und Verwendung | |
| EP0039311B1 (de) | Halogenierte Steroide | |
| EP0003341B1 (de) | 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten | |
| DE2839033A1 (de) | 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung | |
| DE2349023A1 (de) | Neue d-homo-steroide | |
| CH633562A5 (de) | Verfahren zur herstellung neuer kortikoide. | |
| EP0276393B1 (de) | Verfahren zur Herstellung von 6Alpha, 9Alpha-Difluor-11Beta, 17Alpha-dihydroxy-16Alpha-methyl-4-pregnen-3,20-dion und dessen Derivate | |
| EP0013959B1 (de) | Neue D-Homosteroide, Verfahren zu deren Herstellung und diese D-Homosteroide enthaltende Arzneimittel | |
| DE1904544C3 (de) | Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-KetoA<·4 -Steroide | |
| DE2059310C3 (de) | diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung | |
| EP0033120B1 (de) | 1-Hydroxysteroide, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten | |
| EP0032103B1 (de) | Neue Kortikoid-17-thioacetale, ihre Herstellung und Verwendung | |
| DE1904543C3 (de) | Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-Keto- A4 -Steroide | |
| DE2753839A1 (de) | Neue kortikoide | |
| DE2656575A1 (de) | Neue kortikoide | |
| DE1150385B (de) | Verfahren zur Herstellung von 6ª‡-Halogen-bzw. 6ª‡, 9ª‡-Dihalogen-pregnenen | |
| CH629828A5 (en) | Process for the preparation of D-homosteroids | |
| DE1158063B (de) | Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen | |
| DE2803661A1 (de) | Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung | |
| DE2144585A1 (de) | Ester von 9alpha-fluor-16-methylenprednisolon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |